tiprankstipranks
Trending News
More News >
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
US Market
Advertisement

Integra Lifesciences (IART) Ownership - Who Owns Integra Lifesciences?

Compare
246 Followers

Integra Lifesciences (IART) Ownership Overview

3.35%33.69%1.67%27.76%33.53%
1.67% Other Institutional Investors
27.76% ETFs
33.53% Public Companies and
Individual Investors
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail, and individual investors. Approximately 63.12% of the company’s stock is owned by Institutional Investors, 3.35% is owned by Insiders, and 33.53% is owned by Public Companies and Individual Investors.
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail, and individual investors. Approximately 35.36% of the company’s stock is owned by Institutional Investors, 3.35% is owned by Insiders, and 27.76% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 04, 2024
xxxxxxxxxxxxx
$100081
Dec 03, 2024
xxxxxxxxxxxxx
$41055
Aug 20, 2024
xxxxxxxxxxxxx
$25690

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$2155020
Mar 31, 2025
xxxxxxxxxxxxx
$17479081

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,021,668Institution12.90%121,262,183
6,907,154Institution8.89%83,576,563
5,791,984Institution7.45%70,083,006
3,336,268Institution4.29%40,368,843
3,130,919Institution4.03%37,884,120
2,430,000Institution3.13%29,403,000
2,000,000Institution2.57%24,200,000
1,785,271Insider2.30%21,601,779
1,352,936Institution1.74%16,370,526
1,303,030Institution1.68%15,766,663

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,791,984Institution7.45%70,083,006
3,336,268Institution4.29%40,368,843
3,130,919Institution4.03%37,884,120
1,303,030Institution1.68%15,766,663
1,150,073Institution1.48%13,915,883
796,433Institution1.02%9,636,839
791,470Institution1.02%9,576,787
786,298Institution1.01%9,514,206
771,641Institution0.99%9,336,856
658,337Institution0.85%7,965,878

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,003,323Institution5.15%46,999,012
2,257,075Institution2.90%120,708,371
2,096,626Institution2.70%25,725,601
1,689,029Institution2.17%19,829,200
1,613,381Institution2.08%19,796,185
1,040,146Institution1.34%12,762,591
1,029,859Institution1.33%12,636,370
626,563Institution0.81%7,355,850
577,472Institution0.74%6,779,521
569,921Institution0.73%6,958,735

FAQ

Who Owns Integra Lifesciences Holdings Corp. (IART)?
According to the latest TipRanks data, approximately 1.67% of the company's stock is held by institutional investors, 3.35% is held by insiders, and 33.53% is held by retail investors.
    What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.67% of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors.
      What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.53% of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors.
        Who owns the most shares of Integra Lifesciences Holdings Corp. (IART)?
        iShares owns the most shares of Integra Lifesciences Holdings Corp. (IART).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis